Literature DB >> 20023538

Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine.

David Choi1, Robert Melcher, Jürgen Harms, Alan Crockard.   

Abstract

OBJECTIVE: To study the outcomes of surgery for chordomas of the craniocervical junction and upper cervical spine as well as complication rates, survival, and associated adverse factors.
METHODS: Retrospective review of patients (1982-2007) at 2 European centers who underwent transoral, transfacial, transmandibular, and anterior cervical approaches for excision of chordomas of the craniocervical junction and cervical spine. The chi test and Fisher exact test were used to determine significant adverse factors (P < .05), and log-rank survival analysis was used to compare outcome in different groups.
RESULTS: One hundred thirty-two operations were performed in 97 patients. The most common operations were transoral surgeries and maxillotomies. After surgery, neck pain was the same or better in 98.1% of patients. Of the 18.6% of patients who presented with myelopathy, 27.8% improved, 44.4% remained unchanged, and 27.8% deteriorated. Major complication rates were velopharyngeal incompetence, 3.1%; vertebral artery stroke, 1%; wound infection, 3.1%; dysphagia, 3.1%; failure of fixation, 2.1%; sepsis, 3.1%; meningitis, 3.1%; and cerebrospinal fluid leakage, 6.2%. Five- and 10-year overall survivals were 55% and 36%, respectively. Patients who presented to our units for revision surgery, after prior attempts at resection elsewhere, were associated with a worse survival than patients who underwent de novo surgery.
CONCLUSION: We present, to our knowledge, the largest published series of chordomas at the craniocervical junction. Complication rates for these major operations can be minimized at specialist centers, with careful patient selection and counseling. As complete or as radical an operation as possible should be performed at first presentation; the best chance for the patient is the first chance.

Entities:  

Mesh:

Year:  2010        PMID: 20023538     DOI: 10.1227/01.NEU.0000362000.35742.3D

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Clinical results of carbon-ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas.

Authors:  Yoshihiro Matsumoto; Akira Matsunobu; Kenichi Kawaguchi; Mistumasa Hayashida; Keiichiro Iida; Hirokazu Saiwai; Seiji Okada; Makoto Endo; Nokitaka Setsu; Toshifumi Fujiwara; Shingo Baba; Satoshi Nomoto; Yasuharu Nakashima
Journal:  Int J Clin Oncol       Date:  2019-07-06       Impact factor: 3.402

Review 2.  Surgical complications of extraspinal tumors in the cervical spine: a report of 110 cases and literature review.

Authors:  WenHua Yang; Liang Jiang; XiaoGuang Liu; Feng Wei; Miao Yu; FengLiang Wu; Lei Dang; Hua Zhou; Hua Zhang; ZhongJun Liu
Journal:  Eur Spine J       Date:  2017-08-17       Impact factor: 3.134

3.  Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.

Authors:  Ziya L Gokaslan; Patricia L Zadnik; Daniel M Sciubba; Niccole Germscheid; C Rory Goodwin; Jean-Paul Wolinsky; Chetan Bettegowda; Mari L Groves; Alessandro Luzzati; Laurence D Rhines; Charles G Fisher; Peter Pal Varga; Mark B Dekutoski; Michelle J Clarke; Michael G Fehlings; Nasir A Quraishi; Dean Chou; Jeremy J Reynolds; Richard P Williams; Norio Kawahara; Stefano Boriani
Journal:  J Neurosurg Spine       Date:  2015-12-18

Review 4.  The biological basis for modern treatment of chordoma.

Authors:  Roberto Jose Diaz; Michael D Cusimano
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

5.  The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series.

Authors:  Franco DeMonte; Shaan M Raza; Solon Schur; Joel Z Passer; Ehab Y Hanna; Shirley Y Su; Michael E Kupferman
Journal:  J Neurooncol       Date:  2022-08-16       Impact factor: 4.506

6.  Reduction in range of cervical motion on serial long-term follow-up in patients undergoing oblique corpectomy for cervical spondylotic myelopathy.

Authors:  Mazda K Turel; Sauradeep Sarkar; Krishna Prabhu; Roy T Daniel; K S Jacob; Ari G Chacko
Journal:  Eur Spine J       Date:  2013-03-01       Impact factor: 3.134

7.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

8.  Surgical resection of neoplastic cervical spine lesions in relation to the vertebral artery V2 segment.

Authors:  Mohamed Al Barbarawi; Ziad Odat; Mwaffaq Alheis; Suhair Qudsieh; Tareq Qudsieh
Journal:  Neurol Int       Date:  2010-06-21

9.  Surgical Strategy for Skull Base Chordomas : Transnasal Midline Approach or Transcranial Lateral Approach.

Authors:  Benlin Wang; Qi Li; Yang Sun; Xiaoguang Tong
Journal:  J Korean Neurosurg Soc       Date:  2022-03-15

10.  Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.

Authors:  Ke Wang; Kaibing Tian; Liang Wang; Zhen Wu; Cong Ren; Shuyu Hao; Jie Feng; Junhua Li; Hong Wan; Guijun Jia; Liwei Zhang; Junting Zhang
Journal:  Mol Med Rep       Date:  2015-06-22       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.